The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

Precision medicine has revolutionised cancer treatments; however, actionable biomarkers remain scarce. To address this, we develop the Oncology Biomarker Discovery (OncoBird) framework for analysing the molecular and biomarker landscape of randomised controlled clinical trials. OncoBird identifies b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohnmacht, Alexander J., Stahler, Arndt, Stintzing, Sebastian, Modest, Dominik P., Holch, Julian W., Westphalen, C. Benedikt, Hölzel, Linus, Schübel, Marisa K., Galhoz, Ana, Farnoud, Ali, Ud-Dean, Minhaz, Vehling-Kaiser, Ursula, Decker, Thomas, Moehler, Markus, Heinig, Matthias, Heinemann, Volker, Menden, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477267/
https://www.ncbi.nlm.nih.gov/pubmed/37666855
http://dx.doi.org/10.1038/s41467-023-41011-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477267/
https://www.ncbi.nlm.nih.gov/pubmed/37666855
http://dx.doi.org/10.1038/s41467-023-41011-4

Ejemplares similares